Today: 15 May 2026
Coca-Cola stock price slips despite Wells Fargo target hike as KO earnings loom
9 February 2026
2 mins read

Coca-Cola stock price slips despite Wells Fargo target hike as KO earnings loom

NEW YORK, Feb 9, 2026, 15:33 EST — Regular session

  • Coca-Cola shares slipped roughly 1%, with consumer staples trailing the tech-driven bounce in the market.
  • Wells Fargo bumped its price target on Coca-Cola up to $87, sticking with its “overweight” rating.
  • Tuesday’s results are on traders’ minds as they hunt for clues about 2026. U.S. jobs and inflation numbers are also coming up later this week.

Coca-Cola (KO) slipped 1.2% to $78.08 in the afternoon session Monday, trading around 14.6 million shares. The whole consumer staples sector leaned lower—Consumer Staples Select Sector SPDR Fund (XLP) dropped 0.6%. PepsiCo (PEP) sank 2.5%.

Staples lagged behind as tech led a rebound, sending the S&P 500 higher—leaving the group as the session’s biggest drag. “You’ve a sharply oversold market where a little bit of good news can go a long way,” said Keith Lerner, chief investment officer at Truist Advisory Services, summing up the mood behind the rally. Reuters

Timing is key for Coca-Cola. The soft drink giant reports quarterly results Tuesday, with investors zeroed in on demand trends and any fresh details on its 2026 strategy.

Wells Fargo bumped up its price target on Coca-Cola, now pegging the stock at $87 versus the previous $79, and stuck with its “overweight” call on Monday. That label signals the analyst thinks owning more Coca-Cola than the average benchmark makes sense, expecting it to outperform rivals. MarketScreener

Nik Modi over at RBC Capital Markets sees Coca-Cola sticking to earnings estimates and rolling out what he described as “standard” guidance. He flagged the stock’s “safe haven” status after the latest market volatility. Options activity is signaling about a 3% swing either way on the results, according to TipRanks data. TipRanks

Investors dialing into the call are keen to hear how much further Coca-Cola can raise prices before volume starts slipping. They’ll also be weighing any remarks on product mix — that’s the split between premium items and the company’s regular lineup — and parsing for clues about demand in North America compared with overseas markets.

Costs lurk in the backdrop. Packaging, sweeteners, freight—any of those can shift quickly. Currency volatility, too: sometimes it helps, other times it hurts, for a company shipping products globally.

But there’s risk on both sides here. Coca-Cola tends to act like a safety play when markets get rough, yet if executives flag any weakness in volumes or signal more promotions are creeping in, shares could slip further—even if top-line results look good.

The Coca-Cola Company has scheduled its fourth-quarter 2025 earnings call for February 10 at 8:30 a.m. ET, according to its investor relations calendar.

The company is set to take the stage at the CAGNY 2026 Conference on Feb. 17, with its presentation slated for 10:00 a.m. ET. It’s another marker for the firm’s longer-term communications.

On top of the company headlines, traders have their eyes on upcoming U.S. data: January payrolls hit Wednesday, with consumer price inflation due Friday. Any signs of a turn in rate expectations could ripple through demand for defensive stocks.

Stock Market Today

  • RenovoRx Q1 Loss Matches Estimates, Revenue Beats Expectations
    May 14, 2026, 6:48 PM EDT. RenovoRx, Inc. (RNXT) reported a first-quarter loss of $0.08 per share, aligning with Zacks Consensus Estimates. Revenue came in at $0.56 million, exceeding estimates by 12.6% and showing growth from $0.2 million a year ago. The company has missed EPS estimates over the past year but outperformed revenue forecasts twice in four quarters. Despite this, RNXT shares have gained only around 1% year-to-date, compared to the S&P 500's 8.8% rise. The stock holds a Zacks Rank #3 (Hold), indicating expected market-line performance ahead. Investors will watch management's commentary and revisions to earnings forecasts closely, given the Medical - Biomedical and Genetics industry ranks in the bottom 41% among 250 industries by Zacks.

Latest articles

Amazon Stock Falls Today: Why AMZN Slipped While Tech Hit Fresh Highs

Amazon Stock Falls Today: Why AMZN Slipped While Tech Hit Fresh Highs

15 May 2026
Amazon shares fell 1.1% to $267.22 on Thursday, underperforming record highs in the S&P 500 and Nasdaq. Investors focused on Amazon’s rising AI and cloud spending, with little expectation of relief from lower U.S. rates. First-quarter revenue rose 17% to $181.5 billion, but free cash flow dropped sharply due to higher capital spending.
Unusual Machines Stock Jumps As Q1 Revenue Nearly Quadruples And Drone Supply Bet Widens

Unusual Machines Stock Jumps As Q1 Revenue Nearly Quadruples And Drone Supply Bet Widens

15 May 2026
Unusual Machines reported first-quarter revenue of $8.1 million, up 296% from a year earlier, and net income of $10.3 million driven by investment gains despite an operating loss. Shares rose 12.8% to $16.93 after the results. The company raised $150 million in equity and agreed to buy battery maker DroneNX for up to $52 million. Headcount rose to over 190 as of Thursday.
Microsoft Stock Rises As AI Trade Reignites: Why MSFT Shares Moved Today

Microsoft Stock Rises As AI Trade Reignites: Why MSFT Shares Moved Today

15 May 2026
Microsoft shares rose 1.04% to $409.43 on Thursday as investors favored large tech stocks amid record highs for the S&P 500 and Nasdaq. Microsoft reported March-quarter revenue up 18% to $82.9 billion, with Azure and cloud services up 40%. The company expects $190 billion in capital expenditures this year, well above analyst estimates. Microsoft is also exploring AI startup deals as it reassesses its reliance on OpenAI.
United States Antimony Stock Falls After $11.3 Million Loss as Defense Contract Ramp Awaits

United States Antimony Stock Falls After $11.3 Million Loss as Defense Contract Ramp Awaits

15 May 2026
United States Antimony posted a first-quarter net loss of $11.3 million, or 8 cents a share, on $6.8 million in revenue, down from a $546,524 profit a year earlier. Shares fell about 4% to $9.57 in late trading. The company completed initial deliveries under a $245 million Defense Logistics Agency contract but did not recognize revenue from it in the quarter. Gross profit dropped to $1.1 million from $2.4 million.
Why Constellation Energy (CEG) stock is up today: new 380‑MW Texas data center deal
Previous Story

Why Constellation Energy (CEG) stock is up today: new 380‑MW Texas data center deal

RELX share price edges higher — what to watch before Thursday’s results
Next Story

RELX share price edges higher — what to watch before Thursday’s results

Go toTop